Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...
Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. The study focuses on the adenomatous ...
Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability ...
This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.
The initiatives are being implemented in collaboration with partners including the Rwanda Council of Veterinary Doctors (RCVD), Zipline, the International Fund for Agricultural Development (IFAD), the ...
Stanley Plotkin, the virologist whose RA 27/3 rubella vaccine has immunized hundreds of millions of children worldwide, has ...
The SCI treatment pipeline continues to expand, featuring candidates such as KP-100IT (Kringle Pharma), Neuro-Cells ...
Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
8d
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
SHELTON, CT / ACCESS Newswire / April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today ...
WSU veterinarians implant a pacemaker to stop a Czech shepherd’s sudden collapses. During the peak of the COVID-19 pandemic, ...
In this interview, Dr. John Bishop discusses the scientific and regulatory challenges of NAM adoption, where companies should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results